Description

Storage 
Store at 20
°-25°C (68°-77°F) [see USP Controlled Room Temperature]. 
REFERENCES 
7. Tahata T, Shigehito M, Kusuhara K, Ueda Y, et al. Delayed-Onset of Heparin Induced Thrombocytopenia – 
A Case Report – J Jpn Assn Torca Surg.1992;40(3):110-111. 

---

NDA 17-037/S-158 
Page 31 
8. Warkentin T, Kelton J. Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis. Annals of 
Internal Medicine. 2001;135:502-506. 
9. Rice L, Attisha W, Drexler A, Francis J. Delayed-Onset Heparin Induced Thrombocytopenia. Annals of 
Internal Medicine, 2002;136:210-215. 
10. Dieck J., C. Rizo-Patron, et al. (1990). “A New Manifestation and Treatment Alternative for Heparin-
Induced Thrombosis.” Chest 98(1524-26). 
11. Smythe M, Stephens J, Mattson. Delayed-Onset Heparin Induced Thrombocytopenia. Annals of Emergency 
Medicine, 2005;45(4):417-419. 
12. Divgi A. (Reprint), Thumma S., Hari P., Friedman K., Delayed Onset Heparin-Induced Thrombocytopenia 
(HIT) Presenting After Undocumented Drug Exposure as Post-Angiography Pulmonary Embolism. Blood. 
2003;102(11):127b. 
ESI logo, Hep-Lock and Dosette are registered trademarks of Baxter International, Inc., or its 
subsidiaries. 
Manufactured by 
Baxter Healthcare Corporation 
Deerfield, IL 60015 USA 
For Product Inquiry 1 800 ANA DRUG (1-800-262-3784) 
MLT-00090/5.0